# The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.

> **NCT04605627** · — · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Intestinal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04605627
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-08
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04605627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04605627, "The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04605627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*